2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$3.60+$0.20 (+5.74%)
Price as of Jun 03, 2026 7:59 PM EDT- $45.8MMarket Cap
- 16.15%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$3.60+$0.20 (+5.74%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.40 | ||
Change | $0.00 (0.00%) | ||
Open | $3.77 | ||
High | $3.77 | ||
Low | $3.26 | ||
Previous Close | $3.74 | ||
Volume | 192,131 | ||
30-Day Average Volume | 310,406 | ||
1-Week Change | 10.65% | ||
1-Month Change | 76.42% | ||
1-Year Change | 16.15% | ||
3-Year Change | -25.65% | ||
5-Year Change | -74.44% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $7.2M | ||
Market Cap | $45.8M | ||
Enterprise Value | $40.9M | ||
Period: QTR TTM FY | |||
Revenue | -$59,451.00 | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$3.8M | ||
EBIT | -$3.4M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $3.3M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | -688 | ||
P/B | N/A | ||
P/E | -12 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue